Bayer Vital GmbH
🇩🇪Germany
Clinical Trials
3
Active:3
Completed:0
Trial Phases
0 Phases
Drug Approvals
56
NMPA:56
Drug Approvals
Gadoxetic Acid Disodium Injection
- Product Name
- 普美显
- Approval Number
- 国药准字HJ20150175
- Approval Date
- Jan 15, 2024
NMPA
Gadoxetic Acid Disodium Injection
- Product Name
- 普美显
- Approval Number
- 国药准字HJ20150178
- Approval Date
- Jan 15, 2024
NMPA
Moxifloxacin Hydrochloride and Sodium Chloride Injection
- Product Name
- 拜复乐
- Approval Number
- 国药准字HJ20140424
- Approval Date
- Sep 22, 2023
NMPA
Moxifloxacin Hydrochloride and Sodium Chloride Injection
- Product Name
- 拜复乐
- Approval Number
- 国药准字HJ20140425
- Approval Date
- Sep 22, 2023
NMPA
Moxifloxacin Hydrochloride Tablets
- Product Name
- 拜复乐
- Approval Number
- 国药准字HJ20140722
- Approval Date
- Jun 7, 2023
NMPA
Moxifloxacin Hydrochloride Tablets
- Product Name
- 拜复乐
- Approval Number
- 国药准字HJ20140723
- Approval Date
- Jun 7, 2023
NMPA
Moxifloxacin Hydrochloride Tablets
- Product Name
- 拜复乐
- Approval Number
- 国药准字HJ20140721
- Approval Date
- Jun 7, 2023
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- Next
Clinical Trials
No trials found
News
No news found